Market Introduction
This research report provides insights into the Europe Cancer Vaccines market. The cancer vaccine is a vaccine which either treats existing cancer or prevents cancer from developing. Established cancer treatment vaccines are known as therapeutic cancer vaccines. Some / many of the vaccines are "autologous," are made from patient samples, and are unique to that patient. Additionally the cancer vaccines can be of two type, therapeutic vaccine and preventive vaccines. For instance, Cervarix, Gardasil, Gardasil-9 and Hepatitis B (HBV) vaccine (HEPLISAV-B) are Preventive Cancer Vaccines. Whereas, Bacillus Calmette-Guérin (BCG), Sipuleucel-T (Provenge) are Therapeutic Cancer Vaccines
Market Overview and Dynamics
The Europe cancer vaccines market is expected to reach US$ 4,680.7 million by 2027 from US$ 1,387.2 million in 2019. The market is anticipated to grow with a CAGR of 16.8% from 2020 to 2027. Factors driving demand growth include a rise in the prevalence of cancer worldwide and steps taken by European health research organisations and major players in cancer vaccines. COVID19 has had a substantial effect on the industry due to delays in the supply chain and locking conditions. However, problems in the cancer vaccine industry, such as higher prices for cancer vaccines, impede market growth.
Key Market Segments
In terms of technology, the recombinant cancer vaccines segment held the largest share of the market in 2019; and also is anticipated to register the highest CAGR in the market during the forecast period. In terms of type, the preventive cancer vaccine segment held a larger share of the market in 2019 and also is estimated to register a higher market share in the market during the forecast period. Likewise, in terms of end user, the pediatrics segment held a larger share of the market in 2019 and is estimated to register a higher CAGR in the market during the forecast period.
Major Sources and Companies Listed
The World Health Organization (WHO), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and Canadian MedTech Manufacturers’ Alliance are some of the major primary and secondary sources for the Europe cancer vaccines market included in the report.
Reasons to buy the report
Europe Cancer vaccines Market Segmentation
By Technology
Europe Cancer Vaccines Market – By Type
Europe Cancer Vaccines Market – By Indication
Europe Cancer Vaccines Market– By End Use
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 1,387.2 Million |
| Market Size by 2027 | US$ 4,680.7 Million |
| CAGR (2020 - 2027) | 16.8% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Cancer Vaccines Market is valued at US$ 1,387.2 Million in 2019, it is projected to reach US$ 4,680.7 Million by 2027.
As per our report Europe Cancer Vaccines Market, the market size is valued at US$ 1,387.2 Million in 2019, projecting it to reach US$ 4,680.7 Million by 2027. This translates to a CAGR of approximately 16.8% during the forecast period.
The Europe Cancer Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Cancer Vaccines Market report:
The Europe Cancer Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Cancer Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Cancer Vaccines Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Cancer Vaccines Market
